Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Life Science REIT Plc
-
Form 8.3 - De La Rue Plc
-
Form 8.3 - Assura Plc
-
Sveitarfélagið Árborg – Ársreikningur 2024
-
Freight Technologies Integrates with Blue Yonder TMS Through Bayer to Optimize Supply Chain Efficiency
-
Landstar System to Release First Quarter Results on Tuesday, May 13, 2025
-
XRP News: Investors Rush Into XenDex Presale As Momentum Builds Across the Ripple Ecosystem
-
Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its First Quarter 2025 Financial Results
-
Maris-Tech to Unveil Diamond Ultra at DEFEA 2025: Advanced 360° 3D Situational Awareness Platform for AFVs
-
JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ resolutions to the Annual Shareholders’ Meeting on 25 April 2025
-
Notice of Issuance of LHV Group's New Tier 1 Subordinated Bonds and Early Redemption of existing AT1 Subordinated Bonds (including the record date and redemption date)
-
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
-
Gogo to Report First Quarter 2025 Financial Results on May 9th, 2025
-
TRILLION ENERGY ANNOUNCES 2024 YEAR-END RESERVE REPORT
-
Conifers.ai Taps Former RSA, Cylance and McAfee Leaders for Its Board of Directors
-
Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs
-
TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate Offtake of Critical Minerals from Nodules in the High Seas
-
Hawkins, Inc. Expands Water Treatment Offerings with Complementary Acquisition of WaterSurplus
-
Grayscale Investments Appoints Ramona Boston as Chief Marketing Officer
-
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pou
-
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025
-
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
-
SalesHood Promotes Josh Cruickshank Chief Customer Officer to Drive Global Customer Success and Deliver Business Impact For Our Customers
-
Guckenheimer Tops National Food Service Industry Protein Sustainability Scorecard for Fourth Consecutive Year
-
InspireMD to Announce First Quarter 2025 Financial Results
-
Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs
-
Nextech to Unveil Powerful Eyecare Innovations at ASCRS Annual Meeting
-
Års- och hållbarhetsredovisning för verksamhetsåret 2024
-
Umicore - All agenda items approved at the shareholders' meetings
-
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
-
The Ebony Canal, Narrated by Viola Davis Wins Big with Two International Webby Awards for Black Infant and Maternal Health
-
Prospect Park Announces Full Revocation of Cease Trade Order
-
Nano Dimension Announces Closing of Markforged Acquisition
-
Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price
-
Better Choice Company Cancels Previously Announced Stock Dividend
-
Decisions taken by Suominen Corporation’s Annual General Meeting and the Board of Directors
-
OTCQX Best 50 Virtual Investor Conference: Presentations Now Available for Online Viewing
-
NEO Battery Materials Appoints Kenneth Hoffman, Distinguished Battery Industry Leader and Former McKinsey’s Global Head of Battery Materials, as New Director
-
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
-
Reducto Raises $24.5M Series A Round to Help Enterprises Unlock Unstructured Data
-
Pacific Financial Corp Earns $2.4 Million, or $0.24 per Diluted Share for First Quarter 2025; Board of Directors Approves 5% Stock Buyback Plan; Declares Quarterly Cash Dividend of $0.14 per Share
-
Preferred Bank Reports First Quarter Results
-
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
-
Paddle Finance Announce launch on Berachain: Liquidity Tools for Assets Most Protocols Ignore
-
TGI Fridays Appoints Phil Broad as President of International Franchising
-
BTS Group’s Annual Report 2024 is now available online
-
Nexxen to Host Inaugural Investor Day on May 22, 2025
-
Swiss Properties Invest A/S: Results of the Annual General Meeting
-
Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025
-
Porsche celebrates fifty years since the original audacious adventure

